Skip to main content
. 2018 Feb 21;7(3):565–582. doi: 10.1002/cam4.1298

Figure 3.

Figure 3

(A) The pooled estimate of preoperative Grade 3/4 toxicity for bevacizumab‐relevant cohorts. (B) The results of subgroup analysis of bevacizumab‐relevant cohorts. The pooled estimates of preoperative Grade 3/4 toxicity.